Podcast appearances and mentions of paul frenette

Guest: Dr. Paul Frenette is the Chair and Director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at the Albert Einstein College of Medicine. Dr. Frenette’s research focuses…

http://www.einstein.yu.edu - New research on sickle cell disease by Paul Frenette, M.D., has found that using antibiotics to deplete the body’s microbiome may prevent acute sickle cell crisis and could offer the first effective strategy for warding off the disease’s long-term complications, such as organ failure. The findings were published online on September 16 in the journal Nature. Dr. Frenette is professor of medicine and of cell biology and chair and director of Gottesman Institute for Stem Cell and Regenerative Medicine Research at Albert Einstein College of Medicine.

Dr. Paul Frenette has found that nerves play a critical role in both the development and spread of prostate tumors. The paper was published online July 12, 2013, in Science. Dr. Frenette is professor of medicine and of cell biology and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at Albert Einstein College of Medicine. See accompanying release: http://www.einstein.yu.edu/news/releases/922/nerves-play-key-role-in-triggering-prostate-cancer-and-influencing-its-spread/

http://www.einstein.yu.edu - Paul Frenette, M.D., puts into perspective the promise and challenge of stem cell research as well as established and experimental stem cell treatments. Also meet three young researchers who work in Dr. Frenette’s lab: instructor Christoph Scheiermann, postdoc Sandra Pinho, and Mount Sinai School of Medicine M.D./Ph.D student Jalal Ahmed. Dr. Frenette is director of the Ruth A. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at Albert Einstein College of Medicine of Yeshiva University. This edition of Einstein On, a research and medicine podcast, is hosted by Gordon Earle, associate dean for communications and public affairs.

http://www.einstein.yu.edu - Paul Frenette, M.D., discusses the promise and risks of current stem cell treatments and explains how prospective patients can protect themselves from fraudulent therapies. Dr. Frenette is director of the Ruth A. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at Albert Einstein College of Medicine of Yeshiva University. This edition of Einstein On, a research and medicine podcast, is hosted by Gordon Earle, associate dean for communications and public affairs.

Paul Frenette, M.D., professor of medicine and of cell biology and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at Einstein, discusses the promises and challenges of using and developing stem cell therapies to treat a variety of diseases. Interviewed by Einstein's Paul Moniz. Read full transcript |